ARWR News and Press, Arrowhead Pharmaceuticals Inc. From 05/09/24

2024-05-09 16:01:55 ET More on Arrowhead Pharmaceuticals Arrowhead: RNAi Specialist Struggling To Show A Strong Hand (Rating Downgrade) Arrowhead Pharmaceuticals Q2 2024 Earnings Preview Arrowhead Pharmaceuticals secures $50M milestone from Royalty Pharma See...

- Conference Call and Webcast Today, May 9, 2024, at 4:30 p.m. ET Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2024 second quarter ended March 31, 2024. The Company is hosting a conference call today, May 9, 2024, at 4:30 p.m. ET to discu...

AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...

2024-05-09 05:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-08 11:49:59 ET More on Arrowhead Pharmaceuticals Arrowhead: RNAi Specialist Struggling To Show A Strong Hand (Rating Downgrade) Arrowhead Pharmaceuticals secures $50M milestone from Royalty Pharma Arrowhead Pharmaceuticals jumps amid takeover speculation ...

2024-05-02 16:17:14 ET More on Arrowhead Pharmaceuticals Arrowhead: RNAi Specialist Struggling To Show A Strong Hand (Rating Downgrade) Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 2024 Earnings Call Transcript Arrowhead Pharmaceuticals jumps amid takeover speculation ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced a $50 million milestone payment was received from Royalty Pharma plc (NASDAQ: RPRX). This milestone was triggered after the completion of enrollment of the Phase 3 OCEAN(a) - Outcomes Trial of olpasiran, being conducted by Amgen (NASD...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: 2024 RBC Capital Markets Global Healthcare Conference – May 14-15, 2024 Type: Fireside Chat Presentation Date/Time: May 14, 2024, 9:30 a.m. EDT...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company’s proprietary Targeted RNAi Molecule (TRiM TM ) platform. Eac...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on May 9, 2024, at 4:30 p.m. ET to discuss its financial results for the fiscal second quarter ended March 31, 2024. Webcast and Conference Call and Details Investors may acc...